Glaucoma is an irreversible blinding eye disease characterized by progressive ganglion cell death. To date, IOP control has been almost the only clinical option for the treatment of POAG. However, visual field damage continues ...
Aug 26, 2022
0
4
Researchers from Trinity College Dublin have developed a new gene therapy approach that shows promise for treating the dry form of age related macular degeneration (AMD)—a progressive eye disease that affects up to 10% ...
Aug 25, 2022
0
75
Visual acuity (VA) is better when tested in the clinic versus at home, according to a research letter published online Aug. 18 in JAMA Ophthalmology.
Aug 25, 2022
0
4
Gene therapy has partly restored the function of the retina's cone receptors in two children who were born completely color blind, reports a new study led by University College London (UCL) researchers.
Aug 23, 2022
2
2081
Cataracts, any ophthalmologist will tell you, are an extremely common side effect of growing older. Live long enough, and most people will develop this condition—a clouding of the normally clear eye lens—in one or both ...
Aug 23, 2022
0
55
A new clinical trial researching treatment for patients with sight loss as a result of diabetes has shown a type of laser treatment to be both cost effective and non-invasive, offering the best option for patients and health ...
Aug 23, 2022
0
9
A metabolite of caffeine, known as 7-MX, may slow the progression of short-sightedness, also known as myopia, in children, suggests observational research published online in the British Journal of Ophthalmology.
Aug 22, 2022
0
50
A University of Tübingen team has discovered how malformations of the blood vessels can occur in mice—yielding information with possible ramifications for retinal disease
Aug 18, 2022
0
6
New research led by scientists at Mass Eye and Ear and Brigham and Women's Hospital, member hospitals of Mass General Brigham, reveals the role that a genetic variant associated with Alzheimer's disease, APOE4, plays in protecting ...
Aug 16, 2022
0
17
In a lookback study of prescribing patterns among thousands of American ophthalmologists and optometrists, Johns Hopkins Medicine researchers concluded that eye doctors who receive even small financial incentives from pharmaceutical ...
Aug 15, 2022
0
82
